Revolution Medicines Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Revolution Medicines Stock Summary

Revolution Medicines competes with Blueprint Medicines, Sana Biotechnology, Kymera Therapeutics, Monte Rosa, and Black Diamond. Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California. Revolution Medicines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 212 people.

Revolution Medicines Key Financial Ratios

Revolution Medicines Key Balance Sheet Accounts

Revolution Medicines Key Income Statement Accounts

Revolution Medicines Key Cash Accounts

Revolution Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Revolution Medicines's current stock value. Our valuation model uses many indicators to compare Revolution Medicines value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Revolution Medicines competition to find correlations between indicators driving Revolution Medicines's intrinsic value. More Info.Revolution Medicines is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Revolution Medicines' Return On Equity is projected to increase based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Revolution Medicines by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Revolution Medicines Systematic Risk

Today, most investors in Revolution Medicines Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Revolution Medicines' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Revolution Medicines growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Revolution Medicines help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Revolution Medicines. We use our internally-developed statistical techniques to arrive at the intrinsic value of Revolution Medicines based on widely used predictive technical indicators. In general, we focus on analyzing Revolution Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Revolution Medicines's daily price indicators and compare them against related drivers.

When running Revolution Medicines' price analysis, check to measure Revolution Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines is operating at the current time. Most of Revolution Medicines' value examination focuses on studying past and present price action to predict the probability of Revolution Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines' price. Additionally, you may evaluate how the addition of Revolution Medicines to your portfolios can decrease your overall portfolio volatility.